A Phase II Clinical Trial of 'Off-the-Shelf' NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Authors :: Jeremy L. Ramdial
Lorlyn Clemente-Sevilla
Doris Soebbing
Bouthaina S. Dabaja
Peter F Thall
Gheath Alatrash
Amin M Alousi
Rohtesh S. Mehta
Uday R Popat
Partow Kebriaei
Betul Oran
Katy Rezvani
Elizabeth J Shpall
Richard E Champlin
Source :: Blood. 140:7484-7485
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools